uz
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Kanalga Telegramโ€™da oโ€˜tish

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Ko'proq ko'rsatish

๐Ÿ“ˆ Telegram kanali ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ analitikasi

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 13 329 obunachidan iborat bo'lib, Tibbiyot toifasida 1 928-o'rinni va Saudiya Arabistoni mintaqasida 5 694-o'rinni egallagan.

๐Ÿ“Š Auditoriya koโ€˜rsatkichlari va dinamika

ะฝะตะฒั–ะดะพะผะพ sanasidan buyon loyiha tez oโ€˜sib, 13 329 obunachiga ega boโ€˜ldi.

29 Iyun, 2026 dagi oxirgi maโ€™lumotlarga koโ€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 168 ga, soโ€˜nggi 24 soatda esa -26 ga oโ€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oโ€˜rtacha 28.47% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 9.84% ini tashkil etuvchi reaksiyalarni toโ€˜playdi.
  • Post qamrovi: Har bir post oโ€˜rtacha 3 795 marta koโ€˜riladi; birinchi sutkada odatda 1 312 ta koโ€˜rish yigโ€˜iladi.
  • Reaksiyalar va oโ€˜zaro taโ€™sir: Auditoriya faol: har bir postga oโ€˜rtacha 37 ta reaksiya keladi.
  • Tematik yoโ€˜nalishlar: Kontent ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ kabi asosiy mavzularga jamlangan.

๐Ÿ“ Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida taโ€™riflaydi:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Yuqori yangilanish chastotasi (oxirgi maโ€™lumot 30 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boโ€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim taโ€™sir nuqtasiga aylantirishini koโ€˜rsatadi.

13 329
Obunachilar
-2624 soatlar
+2647 kunlar
+16830 kunlar
Postlar arxiv
ุนุฏู„ุช ุนู„ู‰ ุงู„ู…ู„ู ูู‚ุท ุณู„ุงูŠุฏ 17 ุตุงุฑ ุจูŠู‡ ุชุนุฏูŠู„ ุงุฐุง ุงุญุฏ ุณุญุจ ุงู„ู…ู„ู ู ุจุณ ุณู„ุงูŠุฏ ูกูง ุฎู„ ูŠุณุญุจู‡

ุดุจุงุจ ู‡ุฐุง ุดุฑุญ ู„ู„ู…ุฑุญู„ุฉ ุงู„ุฎุงู…ุณุฉ ุงู„ุฑุงุจุนุฉ ุงู„ุนุงู… ุดุงุฑุญ ุงู„ู…ูˆุถูˆุน ู„ุง ุชุฏูˆุฎูˆู†

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุงุญู†ุง ุทู„ุงุจ ุตูŠุฏู„ุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ุนุฏู†ู‡ ุจุญุซ ุชุฎุฑุฌ ุนู† ุงู„ู€Skin Care ูˆ ู†ุญุชุงุฌ ู…ุดุงุฑูƒุฉ ุฒู…ู„ุงุฆู†ุง ุงู„ุตูŠุงุฏู„ุฉ ุจุงู„ุงุณุชุจูŠุงู† ุญุชู‰ ู†ูƒู…ู„ ุฌู…ุน ุงู„ุจูŠุงู†ุงุช https://forms.gle/Mxq4vBT1TERcXggG8

https://docs.google.com/forms/d/e/1FAIpQLScsqY5I3nuOTLxT0CeJwcu7y7MwE3DRIqRvYXAZw_QnsTTaSg/viewform?usp=header ุงู„ุณู„ุงู… ุนู„ูŠูƒู…ุŒ ูŠุฑุฌู‰ ุงู„ุชูุถู„ ุจุงู„ู…ุดุงุฑูƒุฉ ููŠ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ุงู„ุนู„ู…ูŠ ุงู„ุฐูŠ ูŠู‡ุฏู ุฅู„ู‰ ู‚ูŠุงุณ ู…ุณุชูˆู‰ ุงู„ูˆุนูŠ ุญูˆู„ ููˆุงุฆุฏ ุฃูˆู…ูŠุบุง-3 ููŠ ุชู‚ู„ูŠู„ ุงู„ุงู„ุชู‡ุงุจุงุช ูˆุชุญุณูŠู† ุฏู‡ูˆู† ุงู„ุฏู…. ู„ู† ูŠุณุชุบุฑู‚ ู…ู† ูˆู‚ุชูƒ ุฃูƒุซุฑ ู…ู† ุฏู‚ูŠู‚ุชูŠู†. ุดูƒุฑุงู‹ ู„ู…ุณุงู‡ู…ุชูƒ!"

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุจู„ุง ุฒุญู…ุฉ ุฅุฐุง ุชฺฏุฏุฑูˆู† ุชู…ู„ูˆู† ู‡ุงูŠ ุงู„ููˆุฑู…ุง ู„ุฅูƒู…ุงู„ ู…ุชุทู„ุจุงุช ุงู„ุชุฎุฑุฌ ูˆู†ูƒูˆู† ุดุงูƒุฑูŠู† ุฃู„ูƒู…. https://docs.google.com/forms/d/e/1FAIpQLSfUfNNexJ6A6dpd_mQm1dX65Mf6kAWx0_PS1v1UsarVWWq8cw/viewform?usp=header

https://docs.google.com/forms/d/e/1FAIpQLSe7YQk0FAs2jefecE0sJ7n3IyVTPhLEaY4-x7HRYReCjn1anw/viewform?usp=header ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ูˆุฑุญู…ุฉ ุงู„ู„ู‡ ุงุญู†ู‡ ู…ุฌู…ูˆุนุฉ ุทู„ุงุจ ุตูŠุฏู„ุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ.... "ุนุฏู†ู‡ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ู„ู…ุนุฑูุฉ ุนุฏุฏ ุงู„ุตูŠุงุฏู„ุฉ ุงู„ูŠ ูŠูˆุตููˆู† ุงู„ุทุฑูŠู‚ุฉ ุงู„ุตุญูŠุญุฉ ู„ุงุณุชุฎุฏุงู… ุงุฌู‡ุฒุฉ ุงู„ุงุณุชู†ุดุงู‚ ู„ู…ุฑุถู‰ ุงู„ุฑุจูˆ ูˆุญุงุจูŠู† ุชุดุงุฑูƒูˆู†ู‡ ุจุฌุฒุก ู…ู† ุฑุญู„ุชู†ู‡ ุจุจุญุซ ุงู„ุชุฎุฑุฌ ๐Ÿค

ุทู„ุงุจ ุงู„ุฑุงุจุนุฉ ุงู„ูุงุฑู…ุง ู…ุซุจุช ุซุงู†ูŠ ุฑุณุงู„ุฉ ูˆุฑู‡ ุนู„ุงุฌูŠุงุช ุงู„ุฎุงู…ุณุฉ๐Ÿ™

Thyroid gland disorders Copy 3.pdf6.07 MB

Adrenal Gland Disorders Copy.pdf8.37 MB

Applied Therapeutic ฤฑฤฑ โ—โ—‹โ—‹โ—โ—‹โ—‹โ—โ—‹โ—‹โ— ุจุงู„ุงุนุชู…ุงุฏ ุนู„ู‰ ุงู„ู…ู†ู‡ุฌ ุงู„ู…ูˆุญุฏ ูขู ูขูฆ 1. Adrenal Gland Disorders โ—PDF โ—Explain 2. Thyroid Gland Disorders โ—PDF โ—Explain 3. Alzheimer Disease โ—PDF โ—Explain 4. Anxiety Disorders โ—PDF โ—Explain 5. Depressive Disorders โ—PDF โ—Explain 6. Schizophrenia โ—PDF โ—Explain 7. Insomnia โ—PDF โ—Explain 8. Contraception โ—PDF โ—Explain 9. Hormone Replacement Therapy โ—PDF โ—Explain 10. Menstruation Related Disorders โ—PDF โ—Explain 11. Cancer Chemotherapy & Treatment โ—PDF โ—Explain 12. Leukemias โ—PDF โ—Explain 13. Lymphomas โ—PDF โ—Explain 14. Breast Cancer โ—PDF โ—Explain 15. Prostate Cancer โ—PDF โ—Explain 16. Adverse Effects Of Chemotherapy โ—PDF โ—Explain ๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ๐“„น๐“„ผ ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ